For what its worth, Jim Cramer mentioned that his show tonight will cover investing in small biotechs. The one biotech that he enthusiatically mentioned that will be covered on the show tonight was IMGN.
Cramer absolutely did not enthusiastically mention IMGN. A caller asked him about whether he should add to his position and Cramer said he would rather see him in Gilead for to take advantage of the potential in the Hep C market instead of IMGN. I was just passing through on a trail of another biopharma stock and ended up here for a second. Apparently this is not a very sophisticated discussion board.
Thanks, did you see that mentioned today? They could use some positive new PR. He's been on Cramer's show several times, so not sure what he would have that is new to discuss. It's curious that Dan's in NYC and ringing the bell, what's the occasion?